Anna Maria Formenti

TL;DR: The focus of this article is to apply the current understanding of vitamin D as a facilitator of immunocompetence both with regard to innate and adaptive immunity and to consider how this may relate to COVID-19 disease.

TL;DR: The 2nd International Conference on Controversies in Vitamin D was held in Monteriggioni (Siena), Italy, September 11-14, 2018 to address ongoing controversies and timely topics in vitamin D research, to review available data related to these topics and controversies and to suggest a research agenda to clarify areas of uncertainty.

TL;DR: Examination of techniques, results, and side effects of surgery, radiotherapy, and medical therapy, and how advances in technology and novel techniques have changed the way these modalities have changed, emphasize how best to implement available treatment options as part of a multidisciplinary approach at Pituitary Tumor Centers of Excellence.

TL;DR: The aim of this study was to investigate the incidence of hypocalcemia in a large single center population of COVID19 patients and evaluate its possible clinical implications.

TL;DR: The proceedings of the conference led to recommendations for areas in need of further investigation through appropriately designed intervention trials, and areas of uncertainly and controversy include the following: daily doses of vitamin D needed to maintain a normal level of 25OHD in the general population.